INSMED INC Public Float
INSMED INC (INSM) had Public Float of $21.10 billion as of 2025-06-30, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-19
- 2025-06-30: Entity Public Float $21.10B.
- 2024-06-30: Entity Public Float $11.00B.
- 2023-06-30: Entity Public Float $3.00B.
- 2022-06-30: Entity Public Float $2.30B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $21.10B 10-K · filed 2026-02-19 |
| 2024-06-30 | $11.00B 10-K · filed 2025-02-20 |
| 2023-06-30 | $3.00B 10-K · filed 2024-02-22 |
| 2022-06-30 | $2.30B 10-K · filed 2023-02-23 |
| 2021-06-30 | $3.20B 10-K · filed 2022-02-17 |
| 2020-06-30 | $2.80B 10-K · filed 2021-02-25 |
| 2019-06-30 | $2.30B 10-K · filed 2020-02-25 |
| 2018-06-30 | $1.80B 10-K · filed 2019-02-22 |
| 2017-06-30 | $1.06B 10-K · filed 2018-02-23 |
| 2016-06-30 | $603.20M 10-K · filed 2017-02-23 |
| 2015-06-30 | $1.49B 10-K · filed 2016-02-25 |
| 2014-06-30 | $772.70M 10-K · filed 2015-02-27 |
| 2013-06-30 | $345.20M 10-K · filed 2014-03-06 |
| 2013-02-28 | $174.00M 10-K · filed 2013-03-18 |
| 2012-03-09 | $98.46M 10-K · filed 2012-03-13 |
| 2011-11-08 | $80.00M 10-Q · filed 2011-11-09 |
| 2011-08-05 | $100.00M 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |